A cable of this invention includes a core comprising a plurality of coated optical fibers and a filling composition of matter which is disposed about the fibers. Typically, the fibers and the filling material are diposed within a tubular member which is disposed within a sheath system. The sheath system include longitudinally extending strength members and a plastic jacket. The filling composition which fills interstices in the core is one which includes an oil constituent which is a relatively high molecular weight aliphatic hydrocarbon. The aliphatic hydrocarbon is a synthetic oil such as polyalphaolefin or mineral oil. A relatively large percent by weight of an antioxidant system is used to prevent thermal oxidative degradation of the filling material as well as of materials in contact with the filling material. Advantageously, for stabilization and metal deactivation, the composition includes zinc dialkyldithiophosphate or diaryldithiophosphate. A styreneethylene propylene copolymer is also included in order to reduce oil separation of the filling material. A fumed silica is used to impart gel properties to the material.

Patent
   5285513
Priority
Nov 30 1992
Filed
Nov 30 1992
Issued
Feb 08 1994
Expiry
Nov 30 2012
Assg.orig
Entity
Large
349
6
all paid
7. A composition of matter for filling optical fiber cables comprising a hydrocarbon, a block copolymer, a colloidal filler and an antioxidant system which includes a hindered phenol sulfide in combination with a metal deactivator selected from the group consisting of dialkyldithiosphates and diaryldithiophosphates.
1. An optical fiber cable, which comprises:
a core comprising at least one optical fiber transmission medium;
a sheath system which is disposed about said core; and
a filling composition of matter which is disposed about the transmission medium in said core, said filling composition of matter comprising a hydrocarbon, a block copolymer, a colloidal filler and an antioxidant system which includes a hindered phenol sulfide in combination with a metal deactivator selected from the group consisting of dialkyldithiophosphates and diaryldithiophosphates.
2. The optical fiber cable of claim 1, wherein said antioxidant system comprises about 1.3 percent by weight of said filling composition.
3. The optical fiber cable of claim 1, wherein said hydrocarbon is aliphatic.
4. The optical fiber cable of claim 3, wherein said aliphatic hydrocarbon comprises a synthetic oil.
5. The optical fiber cable of claim 4, wherein said synthetic oil is selected from the group consisting of polyalphaolefin, polybutene and polypropene.
6. The optical fiber cable of claim 3, wherein said aliphatic hydrocarbon comprises a mineral oil.
8. The composition of matter of claim 7, wherein said antioxidant system comprises about 1.3 percent by weight of said filling composition.
9. The composition of matter of claim 7, wherein said hydrocarbon is aliphatic.
10. The composition of matter of claim 9, wherein said aliphatic hydrocarbon comprises a synthetic oil.
11. The composition of matter of claim 10, wherein said synthetic oil is selected from the group consisting of polyalphaolefin, polybutene and polypropene.
12. The composition of matter of claim 9, wherein said aliphatic hydrocarbon comprises a mineral oil.

This invention relates to an optical fiber cable provided with a stabilized waterblocking material. More particularly, the invention relates to a cable provided with a dripless, non-bleeding, optical fiber coating-compatible and stabilized waterblocking material which fills interstices in a core of the cable.

In the cable industry, it is well known that changes in ambient conditions lead to differences in water vapor pressure between the inside and the outside of a plastic cable jacket. This generally operates to diffuse moisture in a unidirectional manner from the ouside of the cable to the inside of the cable. Eventually, this will lead to an undesirably high moisture level inside the cable, especially if a plastic jacket is the only barrier to the ingress of the moisture. High levels of condensed moisture inside a cable sheath system may have a detrimental effect on the transmission characteristics of a metallic conductor cable.

Furthermore, water may enter the cable because of damage to the cable which compromises its integrity. For example, rodent attacks or mechanical impacts may cause openings in the sheath system of the cable to occur, allowing water to enter, and, if not controlled, to move longitudinally along the cable into splice closures.

In the prior art, various techniques have been used to prevent the ingress of water through the sheath system of a cable and along the core. For example, a metallic shield which often times is used to protect a metallic conductor cable against lightning and rodent attacks is provided with a sealed longitudinal seam. However, the forming of a shield about a cable core requires the use of relatively low manufacturing line speeds. Also, the use of a metallic shield is destructive of the otherwise all-dielectric property of an optical fiber cable. Further, lightning strikes may cause holes in a metallic shield.

It is not uncommon to include provisions in addition to or as an alternative to a metallic shield for preventing the ingress of water into the core. Waterblocking materials have been used to fill cable cores and to coat portions of cable sheath systems to prevent the movement longitudinally thereof of any water which enters the cable. Such a material, typically is referred to as a filling material. In optical fiber cables, a further important function of a filling material is the maintenance of the optical fibers in a low stress state.

As taught in the prior art, U.S. Ser. No. 07/691,770 filed on Apr. 26, 1991 in the name of C. F. Tu, now U.S. Pat. No. 5,187,763, a cable filling material, especially an optical fiber cable filling material, should meet a variety of requirements. Among them is the requirement that the physical properties of the cable remain within acceptable limits over a rather wide temperature range e.g., from about -40° to about 76°C It is desirable that the composition of matter of the filling material be substantially free of syneresis, i.e. have an ability to retain uniform consistency, over the temperature range. Generally, syneresis is controlled by assuring dispersion of an adequate amount of colloidal particles or other gelling agent. Other desirable properties of the compositions include thermal oxidation resistance.

Optical fiber cables have made great inroads into the communications cable market. Although the presence of water itself within an optical fiber cable is not necessarily detrimental to its performance, passage of the water along the cable interior to connection points or terminals or associated equipment inside closures, for example, may cause problems. In both cases, under freezing conditions, the performance of optical fiber deteriorates quickly.

Further complicating the optical fiber cable situation is the introduction of a waterblocking filling material into the cable core in order to prevent the incursion of water. Suitable waterblocking materials in use must yield under strains experienced when the cable is made or handled. Otherwise, movement of the optical fibers within the cable would be prevented and the fibers would buckle because they contact, with a relative small periodicity, a surface of the unyielding filling material. The smaller the periodicity of the fibers when contacting such an unyielding surface, the greater a loss which is referred to as microbending loss.

Typically, microbending loss in optical fiber cables is more difficult to control at long wavelengths than at short ones. Thus the requirements on the mechanical properties of a fiber cable filling material are typically substantially more severe for cable that is to be used at 1.55 μm, for example, than they are if the cable is to be used at shorter operating wavelengths of 1.3 μm, for example. Although, it has been found that some prior art filling materials perform quite satisfactorily at wavelengths up to about 1.3 μm, it has also been found that this is often not the case at longer wavelengths.

Because silica-based optical fibers typically have their lowest losses at or near the 1.55 μm wavelength, there is great interest in operating optical fiber telecommunication systems at approximately that wavelength. Thus, it is important to have available filling compositions for optical fiber cable that has no significant cabling-induced losses at long wavelengths, including about 1.55 μm.

Filling compositions for use in optical fiber cables should have a relatively low shear modulus, Ge. However, it has been determined that, at least for some applications, a low value of Ge of the filling material is not sufficient to assure low cabling loss, and that a further parameter, the critical yield stress, σc, needs to be controlled because it also affects the optical performance of fibers in a cable with a filling material.

Incorporating a block copolymer into the grease-like composition of matter allows a reduction of the amount of colloidal particles that has been added to the mixture to prevent syneresis of the gel. This reduction can result in cost savings. Furthermore, it makes possible the formulation of less bleeding compositions having a very low critical yield stress.

Waterproofing filling materials for use in cables also must pass industry standard drip tests. To pass these tests, filling materials in cable cores must be retained as cable samples, suspended vertically, and subjected to specified elevated temperatures. Some prior art materials, which have been used, perform satisfactorily with respect to microbending and associated losses, but they bleed out excessively and have problems in meeting current drip tests. Also, it is desired that the low mean added losses exhibited by some prior art filling materials at least be met by filling materials which pass the drip test and have suitable low temperature properties.

Oil separation is a property of a grease-like material which describes the tendency to bleed oil during its lifetime. What is desired is a filling material which has an oil separation no greater than 5% when centrifuged at a rotational speed equivalent to a relative centrifugal force of about 26,000 G. for two hours.

The viscosity of the sought after filling material also is important with respect to processing. Because cable drip is related to oil separation, constraints on the sought after filling material include oil separation, critical yield stress and viscosity. These constraints usually are antagonistic to each other. For example, a reduction of oil separation and an increase in cable drip temperature require high viscosity and yield stress whereas to facilitate processing and to reduce optical loss requires low viscosity and yield stress.

Another problem relating to filled optical fiber cables is the compatibility of the filling material with some coating materials which are disposed about drawn optical fiber to protect the optical fiber. If compatibility is lacking, the performance and/or the appearance of the optical fiber could be affected adversely. The compatibility of otherwise suitable prior art filling materials with some coating materials, particularly those which are relatively soft, is something less than desired.

The filling composition of matter is one which includes an oil constituent which is a relatively high molecular weight aliphatic hydrocarbon. The aliphatic hydrocarbon constituent may be a synthetic oil or mineral oil such as polyalphaolefin, for example, or a relatively high molecular weight mineral oil. Relatively low pour point oils are used in order to improve optical loss at low temperatures. A relatively large percent by weight of an antioxidant system is used to prevent thermal oxidative degradation of the filling material as well as of materials in contact with the filling material. A low molecular weight copolymer is also used to reduce oil separation of the filling material.

Although the above-mentioned composition is suitable from many standpoints for ease in waterblocking in an optical fiber cable, there is a desire to improve cost and performance of the composition.

What is sought after is a waterblocking composition which has a lower cost and improved performance over those used in the past. More particularly one of the constituents may not only give improved performance but also may provide synergistic properties.

The foregoing perfomance problems of the prior art have been improved by a cable of this invention having a filling composition of matter disposed in a core thereof. A cable of this invention includes a core comprising a plurality of coated optical fibers and a filling composition of matter which is disposed about the fibers. Typically, the fibers and the filling material are disposed within a tubular member which is disposed within a sheath system. The sheath system includes longitudinally extending strength members and a plastic jacket.

The filling composition which fills interstices in the core is one which includes an oil constituent which is a relatively high molecular weight aliphatic hydrocarbon. The aliphatic hydrocarbon is a synthetic oil or mineral oil such as polyalphaolefin. A relatively large percent by weight of an antioxidant system is used to prevent thermal oxidative degradation of the filling material as well as of materials in contact with the filling material. Advantageously, for stabilization and metal deactivation, the composition includes zinc dialkyldithiophosphate or zinc diaryldithiophosphate. A styrene-ethylene propylene copolymer is included in order to reduce oil separation of the filling material. A fumed silica is also used to impart gel properties to the material.

Other features of the present invention will be more readily understood from the following detailed description of specific embodiments thereof when read in conjunction with the accompanying drawings, in which:

FIG. 1 is a perspective view of an optical fiber cable of this invention which has a core in which is disposed a filling material;

FIG. 2 is an end view in section of the cable of FIG. 1;

Referring now to FIGS. 1 and 2, there is shown a communications cable which may incorporate the improved filling material of the present invention and which is designated generally by the numeral 20 and which has a longitudinal axis 21. It includes a core 22 comprising optical fibers 25--25 which may be arranged in one or more units 24--24. Each of the optical fibers is provided with a protective coating system which typically includes an inner primary coating layer and an outer secondary coating layer. Also, each of the coated fibers may be buffered with an outer layer of polyvinyl chloride (PVC), for example. Each of the units 24--24 may be wrapped with a binder ribbon 23. The core 22 includes a waterblocking material 26 which is disposed within a tubular member 28 of a sheath system 27. The tubular member 28 often is referred to as a core tube.

The tubular member 28 may be enclosed by a metallic shield 29 and an outer plastic jacket 32. The sheath system 27 also may include strength members 30--30. Also, a waterblocking tape 35 may be wrapped about an outer surface of the core tube 28. The tape 35 may be a waterblocking tape which is disclosed, for example, in U.S. Pat. No. 4,867,526 which issued on Sep. 19, 1989 in the name of C. J. Arroyo. Also, the filling material 26 may be used to fill the core of a cable which includes optical fiber ribbons such as those disclosed in U.S. Pat. No. 4,900,176 which issued on Feb. 13, 1990 in the names of K. W. Jackson, et al.

Constraints on the sought after filling material which includes an oil constituent include oil separation, and associated cable drip temperature, critical yield stress and viscosity of the filling material. As mentioned hereinbefore, these constraints usually are antagonistic to each other. Priorly, it has been demonstrated that low pour point oils produce filling materials the critical yield stress of which at low temperatures decreases with decreasing pour point. The pour point of a material is the lowest temperature at which a sample of the material may be poured. Theoretically, the use of a low pour point oil is conducive to the reduction of optical loss at low temperatures. Cable construction and cable processing conditions also affect the optical performance of fibers and, therefore, the benefit of a low pour point oil may become obscured.

The critical yield stress of a filling material is considered to affect the optical performance of fibers in a cable filled with the filling material. The prior art filling material typically has a critical yield stress of 0.0016 psi at room temperature and 0.0096 psi at -40°C The critical yield stress of the filling material 26 should be such that it does not cause an increase in optical fiber loss over that of prior art filling materials at all temperatures.

The viscosity requirement is needed to accommodate processing, not cable performance. The viscosity of prior art filling material as measured by a helipath viscometer should be 15 to 45 units using spindle TB at room temperature. In order to assure the waterhead resistance of an optical fiber cable, it is preferred to have the helipath viscosity in excess of 28 units. It is desired that the viscosity of the filling material be in the vicinity of that of prior art filling materials so that presently available processing facilities can be used.

The composition of matter of the filling material 26 which is used to fill interstices in the core of the cable 20 and which meets the foregoing requirements includes an oil constituent system in the range of about 85 to about 92 percent by weight. A suitable oil constituent is a relatively high molecular weight aliphatic hydrocarbon. By relatively high in this description is meant a molecular weight in excess of about 600.

The aliphatic hydrocarbon constituent may be a relatively high molecular weight mineral oil such as Kaydol available from the Witco Corporation, for example. In the alternative, the aliphatic hydrocarbon constituent may be a synthetic oil or mineral oil such as, polyalphaolefin oil, polypropene oil or polybutene oil for example. Mixtures of polyalphaolefin with mineral oils and polybutene oils also may be used. In a preferred embodiment, the composition includes about 86.7% by weight of a polyalphaolefin such as SHF 402 oil available from the Mobil Corporation. The synthetic oil or mineral oil of the preferred embodiment is a hydrogenated oligomer of alpha-decene and has an average molecular weight of 1280. The viscosity of the oil at 100°C is approximately 40 centistokes. It has a pour point of approximately -40°C

The polyalphaolefin aliphatic hydrocarbon also may be one which is characterized by a viscosity in the range of about 10 to 60 centistokes at 100°C Suitable polybutene oils have a viscosity in the range of 190 to 300 centistokes whereas a suitable mineral oil has a viscosity greater than 150 SUS which equates to about 35 centistokes. If it has a viscosity substantially greater than 10 centistokes, such as, for example, 40 centistokes, the filling material may become more compatible with the coated optical fiber.

Importantly, included in the composition of the filling material 26 in accordance with the present invention is an antioxidant system in the amount of about 1.3% by weight. The antioxidant system of the preferred embodiment of this invention comprises two antioxidant constituents. In particular, one of the antioxidant constituents may be zinc diaryldithiophosphate or dialkyldithiophosphate (ZDDP). The other antioxidant constituent is high molecular weight, hindered phenolic sulfide which is relatively soluble in mineral oil. Acceptable ZDDP antioxidants are available from the Lubritol Corporation under the tradename Lubritol 1370, and 1395 while an acceptable constituent as the phenolic sulfide is available from the Ciba-Geigy Company under the trade designation Irganox 1035. In a preferred embodiment, the filling composition includes approximately 1.0% by weight of Lubritol 1370 and 0.3% by weight of Irganox 1035. This antioxidant system improves the performance of oil.

Advantageously, the ZDDP has other desirable properties. It also serves as an anti-corrosion agent Not to be overlooked is the reduced cost of ZDDP over other stabilizers.

Exemplary compositions of this invention are shown in TABLES I and II, with the constituents being given in percent by weight. A summary of properties also is presented in each TABLE. Included in the TABLES are measurements of the swell of the primary optical fiber coating material, viscosity, oil separation and yield stress at room temperature. Cable drip test results at 65°C are also provided in some of the TABLES. PG,10

TABLE I
__________________________________________________________________________
COMPOSITION & PROPERTIES OF THE FILLING MATERIAL
__________________________________________________________________________
Composition (% by wt)
Fumed Silica
Copolymer
Antioxidant
Oil Cab-O-Sil
Kraton
Lubrizol
Irganox
Lubrizol
Ex.
Kaydol
SHF 402
TS720 G1701 1395 1035 1370
(1)
(2) (3) (4) (5) (6) (7) (8)
__________________________________________________________________________
A -- 86.7 6.0 6.0 -- 0.3 1.0
B -- 86.7 6.0 6.0 -- 0.3 1.0
C -- 86.7 6.0 6.0 -- 0.3 1.0
D -- 86.2 6.0 6.0 -- 0.3 1.5
E 86.53
-- 6.0 6.0 1.17 0.3 --
F 85.87
-- 6.0 6.0 1.83 0.3 --
G 86.7
-- 6.0 6.0 -- 0.3 1.0
H 90.0
-- 4.5 4.2 -- 0.3 1.0
__________________________________________________________________________
Primary
OIT Coating
Hellpath
Oil Yield
at 220°C
Swell
Viscosity
Sep.
Stress
Drip Test
Ex.
(min) (Vol. %)
(Units)
(%) (psi)
at 65°C
at 70°C
(1)
(9) (10) (11) (12)
(13) (14) (15)
__________________________________________________________________________
A 26.5 -- 35.1 1.34
<0.002
Pass --
B 28.6 5.03 32.4 2.14
0.0027
Pass --
C 33.4 -- 33.5 1.63
0.0037
-- Pass
D 31.8 -- -- -- -- -- --
E 49.5 0 -- -- -- -- --
F 56.5 0 -- -- -- -- --
G 45.1 0 -- -- -- -- --
H 34.5 0 20.2 -- 0.0010
-- Pass
__________________________________________________________________________
TABLE II
__________________________________________________________________________
STABILIZATION FOR FILLING COMPOUND
Kraton G-1701, 6 g; CAB-O-SIL TS 720, 6 g;
LUBRIZOL
LUBRIZOL
1370 1395 IRGANOX
IRGANOX
(60%) (60%) 1076 1035 OIT FOUND
OIT PREDICTED
220°C
wt. g wt. g wt. g wt. g min. avg. min.
__________________________________________________________________________
Kaydol, 86.53 g
1.17 0.3 32.90
1.17 0.3 34.65
1.17 0.3 35.80 34.4 24.9
Kaydol, 85.87 g
1.83 0.3 34.50
1.83 0.3 33.60
1.83 0.3 30.50 32.9 38.0
Kaydol, 85.87 g
1.83 0.3 57.20
1.83 0.3 56.10
1.83 0.3 56.10 56.5 60.0
Kaydol, 86.53 g
1.17 0.3 54
1.17 0.3 48.3
1.17 0.3 46.3 49.5 46.9
Kaydol, 86.00 g 1.7 0.3 34.15
1.7 0.3 32.51
1.7 0.3 27.74 31.5 32.2
Kaydol, 86.7 g
1 0.3 47.67
1 0.3 43.55
1 0.3 44.12 45.1 43.5
__________________________________________________________________________

The optimum concentrations of antioxidants in the stabilization system of the present invention were derived from linear regression of the data developed from experiments listed in TABLE I. As an example, a filling compound formulation used included mineral oil, Kaydol (in the amounts depicted in TABLE I), 6% by weight of Kraton 1701, 6% by weight of Cab-O-Sil TS-720 and varying levels of antioxidants.

In general, the oxidative induction time (OIT) value is an indication of the time when the material being tested begins to oxidize. Therefore, the higher the OIT value, the slower the material begins to oxidize. In other words, an antioxidant system with a higher OIT would inhibit oxidation better than a system with a lower OIT value. The antioxidant system of the present invention improves the performance of the oil. The oxidative induction time of the oil of the composition increases with the use of this antioxidant system.

The OIT may be determined by differential scanning calorimetry. Specifically, a thermal analyzer equipped with differential scanning calorimetric cells manufactured by TA Instruments of New Castle, Del. (formerly known as E. I. DuPont Instruments) was used to measure the OIT values presented herein. Furthermore, as stated, the particular antioxidant evaluated as presented in TABLE II included Lubrizol 1395, which is a zinc C1 -C14 alkyldithiophosphate, Irganox 1076, which is a hindered phenol manufactured by Ciba-Geigy, and Irganox 1035.

The oil constituent needs to be thickened so that it will not run out of a cable and so that oil separation is reduced. Oil separation or syneresis is a property of a filling material which describes the tendency to bleed oil during the lifetime of the filling material. One prior art filling material is known to separate oil if left undisturbed for a certain period of time. The syneresis is usually a slow process and, therefor, has to be determined by an accelerated method, centrifugation. As mentioned hereinbefore, it is desired that the filling material 26 be characterized by a 5% maximum oil separation when centrifuged at a rotational speed equivalent to a relative centrifugal force of 26,000 G for two hours. In order to accomplish this, inorganic and organic thickening agents are included in the composition of the filling material.

Colloidal fillers are used as inorganic thickening agents to adjust the yield stress of the composition. Colloidal filler particles in oil gel the oil by bonding surface hydroxyl groups to form a network. Such gels are capable of supporting a load below a critical value of stress. Above this stress level, the network is disrupted, and the material assumes a liquid-like character and flows under stress. Such behavior often is referred to as thixotropic and is desirable to facilitate processing.

Colloidal fillers useful in the cable 20 include colloidal silica, either hydrophilic or hydrophobic, preferably a hydrophobic fumed silica having a BET surface area between about 50 and about 400 m2 /gm. The higher the surface area, the lower the oil separation. An increase in the fumed silica level decreases oil separation, but adversely increases the critical yield stress and the viscosity of the grease. An example of a hydrophobic fumed silica is a polydimethylsiloxane-coated fumed silica having a BET surface area of about 80-120 m2 /gm, containing about 5% b.w. carbon, and being available from the Cabot Corporation of Tuscola, Ill. under the trade designation Cab-O-Sil TS720. An exemplary hydrophilic colloidal material is fumed silica with a BET surface area of about 175-225 m2 /gm, nominal particle size of 0.012 μm, and a specific gravity of 2.2, available form the Cabot Corporation under the designation Cab-O-Sil M-5. Other colloidal fillers that may be useful in the practice of the invention are precipitated silicas and clays such as bentonites, with or without surface treatment. In the preferred embodiment, a hydrophobic fumed silica such as the Cab-O-Sil TS720 fumed silica in the amount of about 4 to 8 percent by weight is used as the inorganic thickening agent.

Oil retention of the filling material 26 may be improved by the addition of one of more organic thickening agents or bleed inhibitors to the composition. Copolymers used as bleed inhibitors are known to reduce the oil separation of a grease-like filling material, and, unlike fumed silica, does not contribute as much to increasing yield stress and viscosity.

The bleed inhibitor may be a block copolymer, a relatively high viscosity semiliquid, sometimes referred to as semisolid, rubber, or other appropriate rubber. Block copolymers and semiliquid rubbers may be referred to collectively as rubber polymers. Incorporating a rubber polymer into the grease-like composition of matter allows a reduction in the amount of colloidal particles that must be added to the mixture to prevent syneresis of the gel and can result in cost savings. Furthermore, it makes possible the formulation of nonbleeding compositions having a relatively low critical yield stress.

Among the block copolymers that can be used in waterblocking compositions for the cable of the invention are styrene-rubber and styrene-rubber-styrene block copolymers having a styrene/rubber ratio between approximately 0.1 and 0.8 and a molecular weight, as indicated by viscosity in toluene at 25°C, of from about 100 cps in a 20% b.w. rubber solution to about 2000 cps in a 15% b.w. rubber solution. Exemplary block copolymers are (a) a styrene-ethylene-propylene block copolymer (SEP), unplasticized, having a styrene/rubber ratio of about 0.59, a specific gravity of about 0.93, a break strength per ASTM D-412 of 300 psi, and being available from the Shell Chemical Company of Houston, Tex., under the trade designation Kraton G1701; (b) a styrene-ethylene-propylene block copolymer having a styrene to rubber ratio of about 0.39 and available from the Shell Chemical Company under the designation G1702; (c) styrene-ethylene butylene-styrene block copolymer (SEBS), unplasticized, and having a styrene/rubber ratio of about 0.16, a specific gravity of about 0.90, 750% elongation, 300 % modulus per ASTM D-412 of 350 psi, and being available from the Shell Chemical Corporation under the trade designation Kraton G1657 and (d) a diblock copolymer of ethylene and propylene (EP) available from the Shell Chemical Company under the designation G1750. Another copolymer which may be used is Kraton 1726 copolymer which is a mixture of 30% styrene-ethylene butylene-styrene triblock copolymer (SEBS) and 70% styrene-ethylene butylene diblock copolymer (SEB). The preferred embodiment includes Kraton G 1701 block copolymer in an amount of about 6 percent by weight.

It is to be understood that the above-described arrangements are simply illustrative of the invention. Other arrangements may be devised by those skilled in the art which will embody the principles of the invention and fall within the spirit and scope thereof.

Kaufman, Stanley, Sheu, Jim J.

Patent Priority Assignee Title
10022078, Jul 13 2004 DEXCOM, INC Analyte sensor
10039480, Jul 27 2001 DexCom, Inc. Membrane for use with implantable devices
10182751, Oct 25 2007 DexCom, Inc. Systems and methods for processing sensor data
10201301, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10231654, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10314525, Jul 13 2004 DexCom, Inc. Analyte sensor
10327638, May 03 2004 DexCom, Inc. Transcutaneous analyte sensor
10349873, Oct 04 2006 DexCom, Inc. Analyte sensor
10478108, Apr 19 2007 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10524703, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
10610135, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10610136, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10610137, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10617336, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10653835, Oct 09 2007 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
10709362, Feb 22 2006 DEXCOM, INC Analyte sensor
10709363, Feb 22 2006 DexCom, Inc. Analyte sensor
10709364, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10716498, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10722152, Feb 22 2006 DexCom, Inc. Analyte sensor
10743801, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10786185, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
10799158, Feb 22 2006 DexCom, Inc. Analyte sensor
10799159, Feb 22 2006 DexCom, Inc. Analyte sensor
10813576, Feb 22 2006 DexCom, Inc. Analyte sensor
10813577, Feb 22 2006 DEXCOM, INC Analyte sensor
10827956, Feb 22 2006 DEXCOM, INC Analyte sensor
10835672, Feb 26 2004 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
10856787, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10898113, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
10898114, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10918313, Feb 22 2006 DexCom, Inc. Analyte sensor
10918314, Feb 22 2006 DexCom, Inc. Analyte sensor
10918315, Feb 22 2006 DexCom, Inc. Analyte sensor
10918316, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10918317, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10918318, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10925524, Mar 10 2005 DEXCOM, INC System and methods for processing analyte sensor data for sensor calibration
10932700, Jun 21 2005 DexCom, Inc. Analyte sensor
10952652, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
10966609, Feb 26 2004 DexCom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
10980452, Feb 22 2006 DexCom, Inc. Analyte sensor
10980461, Nov 07 2008 DexCom, Inc. Advanced analyte sensor calibration and error detection
10993641, Feb 22 2006 DEXCOM, INC Analyte sensor
10993642, Mar 10 2005 DexCom, Inc. Analyte sensor
11000213, Mar 10 2005 DexCom, Inc. System and methods for processing analyte sensor data for sensor calibration
11000215, Nov 07 2008 DEXCOM, INC Analyte sensor
11020031, Nov 07 2008 DEXCOM, INC Analyte sensor
11026605, Feb 22 2006 DEXCOM, INC Analyte sensor
11045120, Feb 22 2006 DEXCOM, INC Analyte sensor
11051726, Mar 10 2005 DexCom, Inc. System and methods for processing analyte sensor data for sensor calibration
11064917, Feb 22 2006 DexCom, Inc. Analyte sensor
11102306, Feb 21 2008 DexCom, Inc. Systems and methods for processing, transmitting and displaying sensor data
11103165, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11160926, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11246990, Feb 26 2004 DexCom, Inc. Integrated delivery device for continuous glucose sensor
11272867, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11272869, Oct 25 2007 DexCom, Inc. Systems and methods for processing sensor data
11331022, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11350862, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11363975, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11373347, Jun 08 2007 DexCom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
11382539, Oct 04 2006 DexCom, Inc. Analyte sensor
11382540, Oct 24 2017 DEXCOM, INC Pre-connected analyte sensors
11399745, Oct 04 2006 DexCom, Inc. Dual electrode system for a continuous analyte sensor
11399748, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11432772, Aug 02 2006 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
11471075, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
11559260, Aug 22 2003 DexCom, Inc. Systems and methods for processing analyte sensor data
11564602, Nov 19 2003 DexCom, Inc. Integrated receiver for continuous analyte sensor
11589823, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
11633133, Dec 05 2003 DexCom, Inc. Dual electrode system for a continuous analyte sensor
11638541, Dec 09 2003 Dexconi, Inc. Signal processing for continuous analyte sensor
11706876, Oct 24 2017 DexCom, Inc. Pre-connected analyte sensors
11744943, Oct 09 2007 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
11883164, Mar 10 2005 DexCom, Inc. System and methods for processing analyte sensor data for sensor calibration
11911151, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
5384880, Dec 03 1993 Alcatel NA Cable Systems, Inc. Dielectric ribbon optical fiber cable
5433872, Jun 22 1990 Rutherford Chemicals LLC Cable grease composition and articles incorporating same
5463711, Jul 29 1994 AT&T SUBMARINE SYSTEMS INC Submarine cable having a centrally located tube containing optical fibers
5698615, May 09 1995 CCS Technology, Inc Cable with a filling compound and method for the manufacture thereof
5737469, Jun 03 1996 BANK OF AMERICA, N A , SUCCESSOR BY MERGER TO LASALLE BANK NATIONAL ASSOCIATION, SUCCESSOR BY MERGER TO LASALLE BANK MIDWEST N A Filling compound for fiber optical cables
6080929, Mar 25 1998 SI GROUP USA USAA , LLC Stabilized filler compositions for cable and wire
6085009, May 12 1998 Alcatel Water blocking gels compatible with polyolefin optical fiber cable buffer tubes and cables made therewith
6256439, Oct 21 1998 FURUKAWA ELECTRIC NORTH AMERICA, INC Lubricant for central core fiber optic cable having stranded ribbons
6278824, Jun 05 1998 PRYSMIAN CAVI E SISTEMI ENERGIA S R L Optical cable with filling material comprising an internal olefin oligomer
6377737, Feb 21 2000 FURUKAWA ELECTRIC NORTH AMERICA, INC Filling compound having alumina gelling agent
6424771, Feb 21 2000 Fitel USA Corporation Optical cable fiber provided with a non-migrating antioxidant
6577796, Oct 07 1998 PRYSMIAN CAVI E SISTEMI ENERGIA S R L Water-resistant cable
6658185, Aug 23 1999 PRYSMIAN CAVI E SISTEMI ENERGIA S R L Optical fiber cable with components having improved compatibility with waterblocking filling compositions
7192450, May 21 2003 DEXCOM, INC Porous membranes for use with implantable devices
7276029, Aug 01 2003 DEXCOM, INC System and methods for processing analyte sensor data
7285726, Aug 25 2005 Nexans Subsea power cable
7310544, Jul 13 2004 DexCom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
7471972, Jul 27 2001 DexCom, Inc. Sensor head for use with implantable devices
7494465, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
7497827, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
7583990, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7599726, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7632228, Jul 27 2001 DexCom, Inc. Membrane for use with implantable devices
7640048, Jul 13 2004 DEXCOM, INC Analyte sensor
7654956, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
7711402, Mar 04 1997 DexCom, Inc. Device and method for determining analyte levels
7713574, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
7774145, Aug 01 2003 DEXCOM, INC Transcutaneous analyte sensor
7778680, Aug 01 2003 DEXCOM, INC System and methods for processing analyte sensor data
7783333, Jul 13 2004 DexCom, Inc. Transcutaneous medical device with variable stiffness
7797028, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7857760, Jul 13 2004 DEXCOM, INC Analyte sensor
7860544, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
7860545, May 21 2003 DEXCOM, INC Analyte measuring device
7869853, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
7875293, May 21 2003 DEXCOM, INC Biointerface membranes incorporating bioactive agents
7885697, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
7885699, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
7896809, Dec 05 2003 DexCom, Inc. Dual electrode system for a continuous analyte sensor
7905833, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
7914450, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7920907, Jun 07 2006 ABBOTT DIABETES CARE, INC Analyte monitoring system and method
7925321, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7933639, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7935057, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
7946984, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
7949381, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
7955261, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7959569, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7976778, Apr 02 2001 Abbott Diabetes Care Inc Blood glucose tracking apparatus
7979104, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7986986, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
7998071, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8000901, Aug 01 2003 DexCom, Inc. Transcutaneous analyte sensor
8005525, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8010174, Aug 22 2003 DEXCOM, INC Systems and methods for replacing signal artifacts in a glucose sensor data stream
8052601, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8060173, Aug 01 2003 DEXCOM, INC System and methods for processing analyte sensor data
8073519, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8073520, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8118877, May 21 2003 DEXCOM, INC Porous membranes for use with implantable devices
8128562, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8150488, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8160669, Aug 01 2003 DEXCOM, INC Transcutaneous analyte sensor
8162829, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8162830, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8167801, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8170803, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8175673, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8177716, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8195265, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8206297, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8216139, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8224413, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226555, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226557, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8226558, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8229534, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8229535, Feb 21 2008 DEXCOM, INC Systems and methods for blood glucose monitoring and alert delivery
8229536, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8231531, Jul 13 2004 DEXCOM, INC Analyte sensor
8231532, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8233958, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8233959, Aug 22 2003 DexCom, Inc.; DEXCOM, INC Systems and methods for processing analyte sensor data
8235896, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8236242, Apr 02 2001 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
8251906, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8255031, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8257259, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8260392, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8260393, Jul 25 2003 DEXCOM, INC Systems and methods for replacing signal data artifacts in a glucose sensor data stream
8265725, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8265726, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8268243, Apr 02 2001 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
8273022, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8275437, Aug 01 2003 DEXCOM, INC Transcutaneous analyte sensor
8275439, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8280475, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8282549, Dec 09 2003 DEXCOM, INC Signal processing for continuous analyte sensor
8282550, Nov 19 2003 DEXCOM, INC Integrated receiver for continuous analyte sensor
8285354, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8287454, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8290560, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8290561, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8290562, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8292810, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8306598, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8311749, Aug 01 2003 DexCom, Inc. Transcutaneous analyte sensor
8313434, Jul 13 2004 DEXCOM, INC Analyte sensor inserter system
8321149, Aug 01 2003 DexCom, Inc. Transcutaneous analyte sensor
8332008, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8346336, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8346337, Nov 05 2007 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8346338, Aug 22 2003 DexCom, Inc. System and methods for replacing signal artifacts in a glucose sensor data stream
8353829, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8357091, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8366614, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8369919, Aug 01 2003 DEXCOM, INC Systems and methods for processing sensor data
8372005, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8374667, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8380273, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8386004, Dec 05 2003 DexCom, Inc. Calibration techniques for a continuous analyte sensor
8391945, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8394021, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8409131, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8412301, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8423113, Jul 25 2003 DEXCOM, INC Systems and methods for processing sensor data
8428679, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8435179, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8442610, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8452368, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8457708, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8463350, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8465425, Nov 01 2005 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8469886, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8473021, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8474397, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8475373, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8480580, Apr 30 1998 ABBOTT DIABETES CARE, INC Analyte monitoring device and methods of use
8480846, Mar 04 2008 Evonik Operations GmbH Silica and also epoxy resins
8483791, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
8483793, Dec 05 2003 DexCom, Inc. Dual electrode system for a continuous analyte sensor
8491474, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8509871, Jul 27 2001 DexCom, Inc. Sensor head for use with implantable devices
8515516, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8515519, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8548551, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8548553, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8565848, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8565849, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8571625, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8588882, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8591455, Feb 21 2008 DEXCOM, INC Systems and methods for customizing delivery of sensor data
8597189, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8612159, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8615282, Jul 13 2004 DEXCOM, INC Analyte sensor
8617071, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8622905, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8622906, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8641619, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8649841, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8652043, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8657745, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8657747, Sep 01 2006 DEXCOM, INC Systems and methods for processing analyte sensor data
8660627, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8663109, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8666469, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8668645, Jan 02 2001 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8670815, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8672844, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8672845, Aug 22 2003 DEXCOM, INC Systems and methods for processing analyte sensor data
8676287, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8688188, Nov 01 2005 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8690775, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8700117, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8731630, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8734346, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8734348, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8738109, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8744545, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8747315, Dec 09 2003 DexCom. Inc. Signal processing for continuous analyte sensor
8750955, Jul 13 2004 DEXCOM, INC Analyte sensor
8761856, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8765059, Apr 02 2001 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
8771187, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8774887, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8774888, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8777853, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8788006, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8788007, Aug 01 2003 DexCom, Inc. Transcutaneous analyte sensor
8788008, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8790260, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8792953, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
8795177, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8801610, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
8801612, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8808182, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
8812072, Jul 13 2004 DexCom, Inc. Transcutaneous medical device with variable stiffness
8812073, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8821400, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8825127, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8840552, Jul 27 2001 DexCom, Inc. Membrane for use with implantable devices
8840553, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8843187, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
8845536, Aug 01 2003 DEXCOM, INC Transcutaneous analyte sensor
8858434, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
8880137, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
8886272, Feb 22 2006 DEXCOM, INC Analyte sensor
8886273, Oct 04 2006 DEXCOM, INC Analyte sensor
8915849, Aug 01 2003 DexCom, Inc. Transcutaneous analyte sensor
8915850, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8920319, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
8974386, Apr 30 1998 ABBOTT DIABETES CARE, INC Analyte monitoring device and methods of use
8986209, Aug 01 2003 DexCom, Inc. Transcutaneous analyte sensor
8989833, Jul 13 2004 DEXCOM, INC Transcutaneous analyte sensor
9011331, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
9011332, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9014773, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9020572, Feb 21 2008 DexCom, Inc. Systems and methods for processing, transmitting and displaying sensor data
9020573, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9042953, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9044199, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9055901, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9060742, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9066694, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9066695, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9066697, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9072477, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9078607, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9078626, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9107623, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
9143569, Feb 21 2008 DEXCOM, INC Systems and methods for processing, transmitting and displaying sensor data
9149219, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9192328, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
9247900, Jul 13 2004 DexCom, Inc. Analyte sensor
9247901, Aug 22 2003 DEXCOM, INC Systems and methods for replacing signal artifacts in a glucose sensor data stream
9282925, Jul 25 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9326714, Apr 30 1998 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9326716, Nov 01 2005 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9328371, Jul 27 2001 DexCom, Inc. Sensor head for use with implantable devices
9351668, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
9364173, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
9414777, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9420965, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
9420968, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9427183, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9451908, Oct 04 2006 DexCom, Inc. Analyte sensor
9477811, Apr 02 2001 Abbott Diabetes Care Inc Blood glucose tracking apparatus and methods
9498155, Dec 09 2003 DEXCOM, INC Signal processing for continuous analyte sensor
9498159, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9510782, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9532741, Jul 27 2001 DexCom, Inc. Membrane for use with implantable devices
9538946, Nov 19 2003 DexCom, Inc. Integrated receiver for continuous analyte sensor
9585607, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9603557, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9610031, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9610034, Jan 02 2001 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
9649069, Aug 22 2003 DexCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
9668677, Jul 13 2004 DexCom, Inc. Analyte sensor
9717449, Oct 25 2007 DexCom, Inc. Systems and methods for processing sensor data
9724045, Aug 22 2003 DEXCOM, INC Systems and methods for replacing signal artifacts in a glucose sensor data stream
9750441, Dec 09 2003 DexCom, Inc. Signal processing for continuous analyte sensor
9750460, Aug 22 2003 DEXCOM, INC Systems and methods for replacing signal artifacts in a glucose sensor data stream
9775543, Jun 21 2005 DexCom, Inc. Transcutaneous analyte sensor
9801572, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9804114, Jul 27 2001 DexCom, Inc. Sensor head for use with implantable devices
9814414, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9833143, May 03 2004 DexCom, Inc. Transcutaneous analyte sensor
9833176, Jul 13 2004 DexCom, Inc. Transcutaneous analyte sensor
9895089, Aug 01 2003 DexCom, Inc. System and methods for processing analyte sensor data
9986942, Jul 13 2004 DEXCOM, INC Analyte sensor
RE44695, Dec 05 2003 DexCom, Inc. Dual electrode system for a continuous analyte sensor
Patent Priority Assignee Title
4701016, Jan 31 1985 Fitel USA Corporation Thixotropic grease composition and cable comprising same
4803244, Nov 16 1987 Union Carbide Corporation Process for the preparation of thermoplastic elastomers
4826278, Apr 10 1985 Fitel USA Corporation Optical fiber cable including a plurality of multifiber units within a single tube and methods of making
4836640, Jun 27 1986 Fitel USA Corporation Depressed cladding optical fiber cable
4844575, Apr 10 1987 Fitel USA Corporation Optical fiber cable
5187763, Apr 26 1991 FURUKAWA ELECTRIC NORTH AMERICA, INC Optical fiber cable having dripless, non-bleeding and optical fiber coating-compatible waterblocking material in core thereof
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Nov 30 1992AT&T Bell Laboratories(assignment on the face of the patent)
Nov 30 1992KAUFMAN, STANLEYAmerican Telephone and Telegraph CompanyASSIGNMENT OF ASSIGNORS INTEREST 0063560725 pdf
Nov 30 1992SHEU, JIM JENQTSONGAmerican Telephone and Telegraph CompanyASSIGNMENT OF ASSIGNORS INTEREST 0063560725 pdf
Mar 29 1996AT&T CorpLucent Technologies IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0120590893 pdf
Nov 16 2001Lucent TechnologiesFitel USA CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0129460578 pdf
Dec 18 2003Fitel USA CorpFURUKAWA ELECTRIC NORTH AMERICA, INC CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0255210684 pdf
Date Maintenance Fee Events
Jul 14 1997M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Jul 18 1997ASPN: Payor Number Assigned.
Oct 20 1998ASPN: Payor Number Assigned.
Oct 20 1998RMPN: Payer Number De-assigned.
Jul 30 2001M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Aug 24 2005REM: Maintenance Fee Reminder Mailed.
Jan 10 2006M1553: Payment of Maintenance Fee, 12th Year, Large Entity.
Jan 10 2006M1556: 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity.


Date Maintenance Schedule
Feb 08 19974 years fee payment window open
Aug 08 19976 months grace period start (w surcharge)
Feb 08 1998patent expiry (for year 4)
Feb 08 20002 years to revive unintentionally abandoned end. (for year 4)
Feb 08 20018 years fee payment window open
Aug 08 20016 months grace period start (w surcharge)
Feb 08 2002patent expiry (for year 8)
Feb 08 20042 years to revive unintentionally abandoned end. (for year 8)
Feb 08 200512 years fee payment window open
Aug 08 20056 months grace period start (w surcharge)
Feb 08 2006patent expiry (for year 12)
Feb 08 20082 years to revive unintentionally abandoned end. (for year 12)